San Diego, CA, United States of America

Eric R Moellering

This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Algal Biotechnology. Top assignees: Viridos, Inc., Synthetic Genomics, Inc., Exxonmobil Research and Engineering Company. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric R Moellering. Retrieved from https://idiyas.com/inventor/eric-r-moellering

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • La Jolla, CA (US) (2014 - 2016)
  • San Diego, CA (US) (2018 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Lipid Productivity
Recombinant Algae
Genome Editing
Microorganisms
Genetic Modification
Photosynthetic Antenna
Algal Mutants
DGAT Genes
Eukaryotic Cells
TPR Domain
Compositions
Methods
18 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eric R. Moellering

Introduction

Eric R. Moellering, based in San Diego, California, is an accomplished inventor with an impressive portfolio of 16 patents. His work focuses on leveraging biotechnology to advance biofuel production, showcasing his commitment to innovation in sustainable energy.

Latest Patents

Among his most notable patents is the invention of recombinant algae that exhibit high lipid productivity. This innovation involves genetically modifying algal organisms to enhance their lipid and biomass productivity. Such advancements in the genetic engineering of algae could lead to the development of biofuels and specialty products, addressing environmental challenges associated with energy production.

Another significant patent is the creation of an RNA-guided endonuclease-expressing algal strain specifically designed for high-efficiency in vivo genome editing. This invention utilizes CRISPR technology to facilitate precise genome editing, enhancing the capacity for mutation generation in various organisms. This breakthrough not only broadens the understanding of genetic manipulation but also has practical applications in biotechnology and agriculture.

Career Highlights

Eric has played pivotal roles at notable companies within the biotechnology sector, including Synthetic Genomics, Inc. and Viridos, Inc. His work at these firms has been instrumental in pushing the boundaries of genetic research and applications, integrating both scientific rigor and innovation.

Collaborations

In his journey as an inventor, Eric has collaborated with esteemed colleagues, including Imad Ajjawi and John Verruto. These partnerships exemplify the importance of teamwork in scientific advancements and demonstrate Eric’s ability to work alongside some of the brightest minds in the industry.

Conclusion

Eric R. Moellering’s contributions to the field of biotechnology through his inventions stand as a testament to the power of innovation. With a focus on sustainable energy solutions, his patents reflect a profound understanding of the intersection between genetics and environmental science, paving the way for a greener future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…